Paul B. Manning

Companies

• Candel TherapeuticsBoard member Jul 26, 2021 to now¹
• Liquidia CorporationBoard member Nov 19, 2020 to now²
• Verrica Pharmaceuticals Inc.Board member Jun 14, 2018 to now³
• Taysha Gene Therapies, Inc.Board member Sep 23, 2020 to Nov 2, 2022⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LLiquidia Corporation LQDA3,330,207 shares⁵$115.8M at $34.78Jun 18, 2026
• CTCandel Therapeutics CADL2,984,752 shares⁶$24.4M at $8.19Feb 26, 2026
• TGTaysha Gene Therapies, Inc. TSHA5,333,333 shares⁷$20.1M at $3.77Jun 3, 2025
• VPVerrica Pharmaceuticals Inc. VRCA3,983,852 shares⁸$15.2M at $3.81Nov 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 16, 2026Granted 5,882 shares of Liquidia Corporation⁵
• Jun 4, 2026Sold 12,610 shares at $64.42 of Liquidia Corporation⁹
• Jun 4, 2026Sold 68,265 shares at $63.83 of Liquidia Corporation⁹
• Jun 4, 2026Sold 19,125 shares at $62.62 of Liquidia Corporation⁹
• Jun 4, 2026Sold 88,487 shares at $64.28 of Liquidia Corporation⁹
• Jun 4, 2026Sold 11,513 shares at $63.13 of Liquidia Corporation⁹
• Feb 23, 2026Bought 550,458 shares at $5.45 of Candel Therapeutics⁶
• Feb 11, 2026Other 55,116 shares at $42.63 of Liquidia Corporation¹⁰
• Feb 11, 2026Other 55,116 shares at $42.63 of Liquidia Corporation¹⁰
• Nov 25, 2025Bought 2,750,762 shares at $4.24 of Verrica Pharmaceuticals Inc.⁸
• Nov 25, 2025Bought 1,375,380 shares at $4.24 of Verrica Pharmaceuticals Inc.⁸
• Sep 2, 2025Sold 74,230 shares at $29.14 of Liquidia Corporation¹¹
• Sep 2, 2025Sold 254,038 shares at $28.67 of Liquidia Corporation¹¹
• Aug 29, 2025Sold 188,232 shares at $27.62 of Liquidia Corporation¹¹
• Aug 28, 2025Sold 154,337 shares at $27.94 of Liquidia Corporation¹¹
• Jun 25, 2025Granted 1,070,663 shares at $4.67 of Candel Therapeutics¹²
• Jun 17, 2025Granted 18,396 shares of Liquidia Corporation¹³
• May 30, 2025Bought 750,000 shares at $2.75 of Taysha Gene Therapies, Inc.⁷
• Dec 16, 2024Bought 750,000 shares at $6.00 of Candel Therapeutics¹⁴
• Dec 16, 2024Bought 500,000 shares at $6.00 of Candel Therapeutics¹⁴
• Nov 26, 2024Gift 450,000 shares of Verrica Pharmaceuticals Inc.¹⁵
• Nov 22, 2024Bought 4,494,382 shares of Verrica Pharmaceuticals Inc.¹⁵
• Nov 22, 2024Bought 18,426,966 shares of Verrica Pharmaceuticals Inc.¹⁵
• Sep 19, 2024Gift 891,870 shares of Verrica Pharmaceuticals Inc.¹⁶
• Sep 19, 2024Gift 891,870 shares of Verrica Pharmaceuticals Inc.¹⁶